B+
Bull case
30%
Probability
Target price
$65.50
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
FTV
FortiveBNYSE / Capital Goods
Last Price
Quote time unavailable
Current thesis
The bull case is supported by accelerating core growth, strong adjusted EPS and cash-flow growth, higher FY2026 guidance, margin expansion in Intelligent Operating Solutions, and sustained repurchases. [#SEC-8K-2026-07-29]
Posture
Constructive
Lead driver
Value
What changed
3 setup hits (3d) with net bullish as of 2026-10-25.
What can break
Advanced Healthcare Solutions adjusted EBITDA margin declined 80 basis points year over year in Q2. [#SEC-8K-2026-07-29]
Momentum
77
Value
56
Sentiment
58
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $62.20 · Bull $65.50 · Bear $56.25Analysis 2026-08-03; returns require an exact persisted reference.
Earnings
2026-10-28 · BMO
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $62.79
Why
Momentum77 · Δ7d -3.6
Value56 · Δ7d -0.8
Sentiment58 · Δ7d -4.8
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Confirming evidence
- • 3 setup hits (3d) with net bullish as of 2026-10-25.
- • Next scheduled catalyst: earnings 2026-10-28 · BMO.
- • Value remains the lead driver in the composite, 7D delta -0.8.
Contradictions & invalidation
- • Advanced Healthcare Solutions adjusted EBITDA margin declined 80 basis points year over year in Q2. [#SEC-8K-2026-07-29]
- • FY2026 guidance depends on continued execution of the Fortive Accelerated strategy, innovation and commercial initiatives, and recurring-customer-value investments. [#SEC-8K-2026-07-29]
- • The bear case centers on limited evidence of broad-based margin improvement because Advanced Healthcare Solutions margin weakened, alongside higher long-term debt and a negative post-print relative-performance signal.
Catalyst clock
2026-10-28 · BMO
Q2 results and guidance raise support near-term reassessment
Lead driver: Value · See fundamentals
Momentum
77
8% active weight
Current posture
7d trendSoftening
Δ7d
-3.6
Δ21d
+15.5
Value
56
47% active weight
Current posture
7d trendFlat
Δ7d
-0.8
Δ21d
-1.5
Sentiment
58
45% active weight
Current posture
7d trendSoftening
Δ7d
-4.8
Δ21d
-13.5
Why this grade
Composite grade B. Momentum 77.3 / Value 56.2 / Sentiment 58.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-03. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$62.20
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$56.25
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$18.2B
Beta
1.12
Shares Out
302.02M
P/E (TTM)
27.8
P/S (TTM)
3.03
P/FCF (TTM)
16.97
Rev YoY
+7.9%
EPS YoY
+4.9%
Gross Margin
+61.1%
Op Margin
+18.2%
Net Debt
$2.93B
Current Ratio
1.18
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data